Join
Live feed
·
NEWSReleasevia Quantisnow
Immuron Limited logo

Emerging Growth Research Releases Flash Report on Immuron; Maintains Buy-Extended Rating and Raises Price Target to $4.00

ByQuantisnow·Wall Street's wire, on your screen.
IMRN· Immuron Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMRN (Immuron Limited) and more on Quantisnow.